Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 56Observational 2Expanded_access 1

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 2Corneal Diseases 1

Interventions

Bortezomib 20Blood Specimen Collection 9Surveys and Questionnaires 8Lenalidomide 8Dexamethasone 8pomalidomide 6daratumumab 6Flow Cytometry 6Immunoenzyme Techniques 5Biopsy 5plerixafor 4idecabtagene vicleucel 4carfilzomib 4Standard of Care 4Polymerase Chain Reaction 4Amplified Fragment Length Polymorphism Analysis 4Specimen Handling 3Psychiatric Rehabilitation 3Patient Reported Outcome Measures 3Microarray Analysis 3Melphalan 3Magnetic Resonance Spectroscopy 3Interviews as Topic 3Drug Therapy 3Data Collection 3Cytogenetic Analysis 3Chromatin Immunoprecipitation Sequencing 3talquetamab 2selinexor 2belantamab mafodotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × belantamab mafodotin × Plasma cell × Clear all
NCT05833737 2025-05-08

Corneal Findings in Patients Treated With Belantamab Mafodotin

Medical University of Vienna

Terminated
12 enrolled
Plasma cell

Corneal Diseases, Multiple Myeloma

NCT05393024 2025-01-15

Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

Fondazione EMN Italy Onlus

Completed
78 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡